NEW YORK, Aug. 29, 2017 -- According to a new market research report “Global Nerve Repair and Regeneration Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insight by Product (Neurostimulation and Neuromodulation Devices, Biomaterials), by Application (Neurostimulation and Neuromodulation Surgeries, Diagnostics, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting and Stem Cell Therapy)” published by P&S Market Research, the global nerve repair and regeneration market is expected to grow at a CAGR of 11.9% during 2017 - 2023.
Access Report Overview: https://www.psmarketresearch.com/market-analysis/nerve-repair-and-regeneration-market
According to the study, the global nerve repair and regeneration market is likely to grow significantly during the forecast period, due to increasing geriatric population, rising prevalence of chronic pain and increasing incidence of neurological disorders. In addition, the awareness about mental diseases and their treatment and technological advancement in nerve repair and regeneration products is also increasing globally, which contributes to the growth of the market. Lack of skilled professionals, high cost and side effects associated with the usage of neurostimulation and neuromodulation devices are the key factors restraining the global market growth.
As per the findings of the research, the market for neurostimulation and neuromodulation devices was larger than the market for biomaterials. Internal devices form the larger part of the global neurostimulation and neuromodulation devices market. Within internal neurostimulation and neuromodulation devices, spinal cord stimulation devices generate the largest revenue in the global market. Based on application, neurostimulation and neuromodulation surgeries has been the largest application area of the global nerve repair and regeneration market, followed by direct nerve repair/neurorrhaphy, nerve grafting and stem cell therapy.
Geographically, North America has been the largest market for nerve repair and regeneration, with the U.S. being the largest contributor to the regional market. Increasing incidence of peripheral nerve injuries and presence of technological advanced products has been driving the growth of the North American market. In Europe, Germany has been the largest contributor to the nerve repair and regeneration market, followed by the U.K. and France. The market is expected to witness highest growth in Asia-Pacific, during 2017 - 2023, owing to increasing cases of neurological disorders and increasing geriatric population.
Globally, the aging population plays a key role in the growth of the nerve repair and regeneration market. The elderly people are more susceptible to suffering from chronic pain and neurological disorders, such as Alzheimer’s, epilepsy and Parkinson’s as compared to adults. According to the United Nations Department of Economic and Social Affairs (UN-DESA) report, the number of people aged 60 years or over is projected to grow by 56.0%, globally, i.e. from 901 million in 2015 to 1.4 billion by 2030. Also, by 2050, the global aging population is projected to reach nearly 2.1 billion in number. Additionally, the number of people aged 60 years and above is expected to reach approximately 437 million in China, 324 million in India, 107 million in the U.S. and 58 million in Brazil by 2050.
Make Enquiry Before Buying this Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=nerve-repair-and-regeneration-market
According to American Geriatrics Society (AGS), around 20.0% of Americans are expected to be more than 65 years of age by 2030, and 21.0% of those over 60 years of age are likely to undergo surgical procedures.
Some of the key players in the global nerve repair and regeneration market include Boston Scientific Corporation, Axogen, Inc., Cyberonics, Inc., Medtronic, PLC, Baxter International Inc., St. Jude Medical, Inc., Integra Lifesciences Holdings Corporation, Inc., Stryker Corporation, Orthomed S.A.S. and Polyganics B.V.
Related Reports
Active Implantable Medical Devices Market
Active implantable medical device refers to any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure. Based on the product type different active implantable medical device products include implantable cardioverter defibrillators, neurostimulators, implantable cardiac pacemakers, implantable hearing devices, ventricular assist devices, implantable heart monitors/insertable loop recorders. The global active implantable medical devices market is expected to witness considerable growth during 2017 - 2023.
https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market
Auto-Injectors Market
The global auto-injectors market is expected to witness a CAGR of 18.6% during the forecast period (2017 – 2023). Rising prevalence of anaphylaxis and increasing healthcare spending are some of the key drivers for the global market growth. Additionally, emerging biologic drug therapies, minimized needle-stick injuries and growing aging population also support the growth of the global market.
https://www.psmarketresearch.com/market-analysis/auto-injectors-market
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook


ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 



